Ovarian Cancer Stem Cells Are Enriched in Side Population and Aldehyde Dehydrogenase Bright Overlapping Population

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Yasuda, Kazuyo ^a   Torigoe, Toshihiko ^a   Morita, Rena ^a   Kuroda, Takahumi ^a   Takahashi, Akari ^a   Matsuzaki, Junichi ^a   Kochin, Vitaly ^a   Asanuma, Hiroko ^a   Hasegawa, Tadashi ^a   Saito, Tsuyoshi ^a   Hirohashi, Yoshihiko ^a   Sato, Noriyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; TRANSCRIPTION FACTOR SOX2;

ADIPOCYTE; ALDEHYDE DEHYDROGENASE BRIGHT CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER STEM CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; ENDOMETRIOID CARCINOMA; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; PROTEIN EXPRESSION; SIDE POPULATION CELL;

ALDEHYDE DEHYDROGENASE; ANIMALS; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; HETEROGRAFTS; HUMANS; MICE; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; PHENOTYPE; SIDE-POPULATION CELLS; SOXB1 TRANSCRIPTION FACTORS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84881500995     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068187     Document Type: Article

References (38)

1. Rosen JM, Jordan CT, (2009) The increasing complexity of the cancer stem cell paradigm. Science 324: 1670-1673.
2. Ghaffari S, (2011) Cancer, stem cells and cancer stem cells: old ideas, new developments. F1000 Med Rep 3: 23.
3. Hirohashi Y, Torigoe T, Inoda S, Morita R, Kochin V, et al. (2012) Cytotoxic T lymphocytes: Sniping cancer stem cells. Oncoimmunology 1: 123-125.
4. Dean M, Fojo T, Bates S, (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275-284.
5. Rich JN, (2007) Cancer stem cells in radiation resistance. Cancer Res 67: 8980-8984.
6. Tirino V, Desiderio V, Paino F, De Rosa A, Papaccio F, et al. (2012) Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB J.
7. Lehmann C, Jobs G, Thomas M, Burtscher H, Kubbies M, (2012) Established breast cancer stem cell markers do not correlate with in vivo tumorigenicity of tumor-initiating cells. Int J Oncol 41: 1932-1942.
8. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, et al. (2008) CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 118: 2111-2120.
9. Burkert J, Otto WR, Wright NA, (2008) Side populations of gastrointestinal cancers are not enriched in stem cells. J Pathol 214: 564-573.
10. Pecorelli S, Favalli G, Zigliani L, Odicino F, (2003) Cancer in women. Int J Gynaecol Obstet 82: 369-379.
11. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, et al. (2006) Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci U S A 103: 11154-11159.
12. Deng S, Yang X, Lassus H, Liang S, Kaur S, et al. (2010) Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS One 5: e10277.
13. Zhang S, Balch C, Chan MW, Lai HC, Matei D, et al. (2008) Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68: 4311-4320.
14. Friel AM, Sergent PA, Patnaude C, Szotek PP, Oliva E, et al. (2008) Functional analyses of the cancer stem cell-like properties of human endometrial tumor initiating cells. Cell Cycle 7: 242-249.
15. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC, (1996) Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183: 1797-1806.
16. Inoda S, Hirohashi Y, Torigoe T, Morita R, Takahashi A, et al. (2011) Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells. Am J Pathol 178: 1805-1813.
17. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, et al. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567.
18. Michifuri Y, Hirohashi Y, Torigoe T, Miyazaki A, Kobayashi J, et al. (2012) High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis. Pathol Int 62: 684-689.
19. Billon N, Iannarelli P, Monteiro MC, Glavieux-Pardanaud C, Richardson WD, et al. (2007) The generation of adipocytes by the neural crest. Development 134: 2283-2292.
20. Nakatsugawa M, Hirohashi Y, Torigoe T, Asanuma H, Takahashi A, et al. (2009) Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4. Cancer Sci 100: 1485-1493.
21. Vathipadiekal V, Saxena D, Mok SC, Hauschka PV, Ozbun L, et al. (2012) Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer. PLoS One 7: e29079.
22. Hirohashi Y, Torigoe T, Inoda S, Takahashi A, Morita R, et al. (2010) Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells. Immunotherapy 2: 201-211.
23. Wang YC, Yo YT, Lee HY, Liao YP, Chao TK, et al. (2012) ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome. Am J Pathol 180: 1159-1169.
24. Pierre-Louis O, Clay D, Brunet de la Grange P, Blazsek I, Desterke C, et al. (2009) Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34+CD38- stem/progenitor cell compartment. Stem Cells 27: 2552-2562.
25. Varghese S, Whipple R, Martin SS, Alexander HR, (2012) Multipotent cancer stem cells derived from human malignant peritoneal mesothelioma promote tumorigenesis. PLoS One 7: e52825.
26. Nakatsugawa M, Takahashi A, Hirohashi Y, Torigoe T, Inoda S, et al. (2011) SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity. Lab Invest 91: 1796-1804.
27. Shi MF, Jiao J, Lu WG, Ye F, Ma D, et al. (2010) Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line. Cell Mol Life Sci 67: 3915-3925.
28. Wang L, Mezencev R, Bowen NJ, Matyunina LV, McDonald JF, (2012) Isolation and characterization of stem-like cells from a human ovarian cancer cell line. Mol Cell Biochem 363: 257-268.
29. Clevers H, (2011) The cancer stem cell: premises, promises and challenges. Nat Med 17: 313-319.
30. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, et al. (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648.
31. Bonnet D, Dick JE, (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737.
32. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
33. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, et al. (2009) Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69: 3382-3389.
34. Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, et al. (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468: 829-833.
35. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
36. Silva IA, Bai S, McLean K, Yang K, Griffith K, et al. (2011) Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res 71: 3991-4001.
37. Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, et al. (1997) Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 3: 1337-1345.
38. Ma I, Allan AL, (2011) The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev 7: 292-306.